About KRYSP-R
KRYSP-R is a Healthcare company based in Mount Laurel (United States) founded in 2021 by Yajamana Ramu. Provider of CRISPR technology services for revolutionizing the service sector. KRYSP-R offers products and services including CRISPR Plasmids, Cell Line Generation, and CRISPR Reagents. Its focus areas include Life Sciences, Genomics, Genomics Services and Genome Engineering. Its legal entity in India is Krysp-r Biotech Private Limited (U72100KA2024PTC191861). Its competitors include Strateos, Anthology and Leveragen; 1 of its 3 listed competitors has raised funding.
Company details
KRYSP-R was founded in 2021 and is based in Mount Laurel Township, United States. Operations focus on biotechnology, with services centered on CRISPR technology for genome editing. Plant cell lines are edited for research applications, while gene knock-ins or knockouts are created in mammalian cell lines to examine diseases and potential treatments. The genetic composition and functions of microorganisms are also studied to pinpoint essential drug targets.
- Headquarters Mount Laurel, United States
- Founders Yajamana Ramu
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website kryspr.org
- Social LinkedIn YouTube
- Legal Name Krysp-R Biotech Private Limited
- Date of Incorporation 08 Aug, 2024
- Jurisdiction Bangalore, Karnataka, India
Associated legal entities of KRYSP-R
KRYSP-R operates through Krysp-R Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Krysp-R Biotech Private Limited CIN U72100KA2024PTC191861 | Active | 08 Aug 2024 | Bangalore, Karnataka | 2 | View details |
Products & Services of KRYSP-R
KRYSP-R offers a comprehensive portfolio of products and services, including CRISPR Plasmids, Cell Line Generation, and CRISPR Reagents.
Plasmids for reliable genome editing applications.
Service to generate cell lines using CRISPR technology.
Reagents for various CRISPR-based research needs.
Apps and channels of KRYSP-R
its YouTube channel Avas WordPress Theme has 234 subscribers and 30 videos.
Videos from KRYSP-R
The most watched videos on KRYSP-R's YouTube channel, Avas WordPress Theme (234 subscribers). Click a video to play it here.
More on Avas WordPress Theme.
Board of directors of Krysp-R Biotech Private Limited (KRYSP-R)
Krysp-R Biotech Private Limited is the primary company behind KRYSP-R. The board of Krysp-R Biotech Private Limited currently have 2 directors; the longest-serving is Raghunathan Diwakaran, appointed in 2024.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Raghunathan Diwakaran DIN 10736386 | Director | 08 Aug 2024 | 2 yrs 3 mo | Krysp-R Biotech Private Limited |
| Balamukundan Viswanadhan DIN 10736385 | Director | 08 Aug 2024 | 2 yrs 3 mo | Krysp-R Biotech Private Limited |
People of KRYSP-R
1 people are tracked at KRYSP-R (1 in leadership).
| Name | Role | Group |
|---|---|---|
Yajamana Ramu | Co-Founder | Leadership |
Complete people profiles for KRYSP-R
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of KRYSP-R
KRYSP-R has 3 listed competitors in our database, 1 of them funded. They include Strateos, Anthology and Leveragen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| strateos.com | 2019 | Menlo Park, United States | $72.6M | 147 | Provider of cloud based platform provides data driven information for biotech research | |
| anthology.bio | 2023 | Cambridge, United States | Diverse genomes are generated to scale biomanufacturing and digitalize processes. | |||
| leveragen.com | 2017 | Cambridge, United States | Customized genetic engineering services are provided using CRISPR technology. |
Detailed competitors of KRYSP-R
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as KRYSP-R (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about KRYSP-R
KRYSP-R was founded in 2021.
KRYSP-R is headquartered in Mount Laurel, United States. It is registered at Mount Laurel, New Jersey, United States.
KRYSP-R was founded in 2021 and is based in Mount Laurel Township, United States. Operations focus on biotechnology, with services centered on CRISPR technology for genome editing. Plant cell lines are edited for research applications, while gene knock-ins or knockouts are created in mammalian cell lines to examine diseases and potential treatments. The genetic composition and functions of microorganisms are also studied to pinpoint essential drug targets.
KRYSP-R offers CRISPR Plasmids, Cell Line Generation, and CRISPR Reagents.
KRYSP-R operates through Krysp-R Biotech Private Limited.
The legal entities of KRYSP-R currently have 2 directors, including Raghunathan Diwakaran, Balamukundan Viswanadhan.